Submission based on positive data from two pivotal studies, which both met their primary endpoints. U.S. clearance expected in Q3 2025 based on average observed review timelines for radiological medical devices.
Submission based on positive data from two pivotal studies, which both met their primary endpoints. U.S. clearance expected in Q3 2025 based on average observed review timelines for radiological medical devices.